Testing effectiveness (Phase 2)Study completedNCT04782323
What this trial is testing
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults
Who this might be right for
Influenza
Seqirus 839
Showing 20 of 0 results